California Sues Krave Kratom Manufacturer for Violating Embargo Orders and Continuing Illegal Distribution

Why it matters

This lawsuit signals California's escalating enforcement posture against kratom manufacturers who repeatedly flout public health orders. With six confirmed deaths in Los Angeles County linked to kratom-derived products, the legal action has direct implications for consumer safety and industry accountability.

The big picture

California has been one of the most aggressive states in pursuing kratom enforcement, having already banned kratom and 7-OH for consumption under the Sherman Food, Drug and Cosmetic Act. The CDPH has seized more than $5 million in kratom and 7-OH products statewide. This lawsuit against Krave Kratom's parent company escalates from administrative enforcement to civil litigation after repeated violations of an existing embargo.

Key findings

• California CDPH and AG Rob Bonta filed suit on May 1, 2026 against Ashlynn Marketing Group (Krave Kratom) in San Diego County Superior Court
• CDPH first inspected the Santee facility in May 2025, finding kratom powders, capsules, liquids and chewable tablets; an embargo was issued
• Follow-up visits in October 2025 and April 2026 found the embargo violated — products were moved, tampered with and repackaged
• Six deaths in Los Angeles County have been linked to kratom-derived and 7-OH products
• The lawsuit seeks to destroy all embargoed products, halt manufacturing, and impose civil penalties up to $1,000 per day per violation

What they say

"7-OH and kratom-derived products have been associated with addiction, serious health harms, overdose and death," said CDPH Director Dr. Erica Pan.

Bottom line

California's civil lawsuit against Krave Kratom's parent company demonstrates that regulators will escalate to litigation when manufacturers continue illegal operations after repeated embargo violations.